Date |
Name of Speaker |
Title |
| November 20, 2002 |
Paul Epstein, Ph.D.
University of Louisville |
Beneficial and Detrimental Effects of Antioxidant Transgenes in Diabetes |
| December 4, 2002 |
William G. Carter, Ph.D.
Fred Hutchinson Cancer Res Center |
Adhesion Events in Epidermal Wound Repair |
| December 18, 2002 |
Steven E Kahn, M.B., Ch.B.
University of Washington |
ß-Cell in Type 2 Diabetes: From Bedside to Bench |
| January 17, 2003** |
John Baynes, Ph.D.
University of South Carolina |
The AGE Inhibitor, Pyridoxamine, Decreases Hyperlipidemia and Inhibits Chemical Modification of Proteins & Development of Pathology in Diabetic & Obese Rats |
| January 22, 2003 |
Terrance J. Kavanagh, Ph.D.
University of Washington |
Glutathione Synthesis, Oxidative Stress and Hepatocyte Cell Death |
| February 12, 2003 |
Wilfred Jefferies, Ph.D.
The University of British Columbia |
Tumour-Immunotherapy with TAP's Resurrects both Antigen Processing in Tumours and Immune Surveillance Mechanisms |
| February 19, 2003 |
Brad Marsh, Ph.D.
University of Colorado |
3D Structure Studies of the Pancreatic Beta Cell by High Resolution Em Tomography |
| March 12, 2003 |
Ronald Kahn, M.D.
Joslin Diabetes Center |
LANGERHANS-VIRCHOW SPEAKER: Genetic Analysis of Insulin and IGF-1 Action |
| March 17, 2003** |
Ignacio J. Melero, M.D., Ph.D.
University of Navarra Medical School
Pamplona Spain |
Strategies of cancer immunotherapy based on Interleukin-12 gene transfer |
| March 19, 2003 |
Jose Russo, M.D.
Fox Chase Cancer Center |
A New Paradigm in Breast Cancer Prevention |
| April 2, 2003 |
Peter Chidiac, Ph.D.
University of Western Ontario |
Receptors and RGS Proteins: The Yin and Yang of Heterotrimeric G Protein Regulation |
| April 16, 2003 |
Jay Heinecke, M.D.
University of Washington |
A Proteomics Approach to Exploring the Role of Oxidative Stress in Diabetes |
| June 4, 2003 |
Thomas Jetton, Ph.D.
University of Vermont |
Mechanisms of ß cell mass compensation |
| July 2, 2003 |
YingMeei Tan, PhD
University of Illinois at Chicago |
Signaling mechanisms involved in betulinic acid-induced apoptosis in human melanoma cells |
| August 4, 2003** |
Bruce Robinson, MD
Queen Elizabeth II Medical Centre |
Tumor Antigens - Cross Presentation, Generation of Detectable Soluble Products and Implications for Development of Tumor Immunotherapies |
| August 18, 2003** |
James J. Mulé, Ph.D.
University of Michigan Cancer Center |
Strategies to improve dendritic cell-based cancer vaccines |
